CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-26 | COZADD BRUCE C Director | Option exercise | +811 | $123.36 | $100K | 470,832 |
| 2025-11-26 | COZADD BRUCE C Director | Sale | −30,487 | $178.06 | $5.4M | 440,345 |
| 2025-11-26 | COZADD BRUCE C Director | Sale | −8,380 | $179.23 | $1.5M | 431,965 |
| 2025-11-26 | COZADD BRUCE C Director | Sale | −507 | $179.79 | $91K | 431,458 |
| 2025-11-26 | COZADD BRUCE C Director | Sale | −38,126 | $177.27 | $6.8M | 393,332 |
| 2025-11-26 | COZADD BRUCE C Director | Option exercise · Incentive Stock Option (right to buy) | −811 | 0 | ||
| 2025-11-26 | COZADD BRUCE C Director | Option exercise · Non-Qualified Stock Option (right to buy) | −76,689 | 0 | ||
| 2025-11-20 | McSharry Heather Ann Director | Option exercise | +3,415 | $138.08 | $472K | 23,864 |
| 2025-11-20 | McSharry Heather Ann Director | Sale | −3,415 | $177.78 | $607K | 20,449 |
| 2025-11-20 | McSharry Heather Ann Director | Option exercise · Non-Qualified Stock Option (right to buy) | −3,415 | 0 | ||
| 2025-11-20 | COZADD BRUCE C Director | Grant or award | +2,506 | 393,332 | ||
| 2025-11-19 | Henderson Mary Elizabeth SVP, Technical Operations | Returned to the company | −1,331 | $180.40 | $240K | 21,746 |
| 2025-11-18 | Carr Patricia SVP, Chief Accounting Officer | Sale | −69 | $181.66 | $13K | 7,012 |
| 2025-11-18 | Carr Patricia SVP, Chief Accounting Officer | Option exercise | +5,250 | $136.18 | $715K | 12,262 |
| 2025-11-18 | Carr Patricia SVP, Chief Accounting Officer | Sale | −5,250 | $182.07 | $956K | 7,012 |
| 2025-11-18 | Carr Patricia SVP, Chief Accounting Officer | Option exercise · Non-Qualified Stock Option (right to buy) | −5,250 | 0 | ||
| 2025-11-18 | Winningham Rick E Director | Sale | −5,500 | $180.86 | $995K | 8,893 |
| 2025-11-18 | COZADD BRUCE C Director | Sale | −3,384 | $180.09 | $609K | 405,442 |
| 2025-11-18 | COZADD BRUCE C Director | Sale | −8,382 | $180.88 | $1.5M | 397,060 |
| 2025-11-18 | COZADD BRUCE C Director | Sale | −5,517 | $181.81 | $1.0M | 391,543 |
Page 9 of 19 · 365 trades